WASHINGTON â — A Pennsylvania drug plant plagued by quality-control problems that prompted a nationwide recall of children’s Tylenol and dozens of other widely used over-the-counter medicines apparently shrank its work force sharply in recent years, according to local government tax records. And a Food and Drug Administration inspection report this year cited failure to properly train contract and temporary employees as part of a lengthy catalogue of quality-control issues at the plant run by McNeil Consumer Healthcare, a subsidiary of pharmaceuticals giant Johnson & Johnson. The performance of McNeil and its parent company, once considered models for their industry, will be examined Thursday at a congressional hearing into what may rank as the biggest recall of pediatric medicines in U.S. history. … Read ahead
Source: articles.mcall.com